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Abstract
Background: The cryptochrome 1 and 2 genes (cry1 and cry2) are necessary for the generation of
circadian rhythms, as mice lacking both of these genes (cry1,2-/-) lack circadian rhythms. We studied
sleep in cry1,2-/- mice under baseline conditions as well as under conditions of constant darkness
and enforced wakefulness to determine whether cryptochromes influence sleep regulatory
processes.
Results: Under all three conditions, cry1,2-/- mice exhibit the hallmarks of high non-REM sleep
(NREMS) drive (i.e., increases in NREMS time, NREMS consolidation, and EEG delta power during
NREMS). This unexpected phenotype was associated with elevated brain mRNA levels of period 1
and 2 (per1,2), and albumin d-binding protein (dbp), which are known to be transcriptionally inhibited
by CRY1,2. To further examine the relationship between circadian genes and sleep homeostasis,
we examined wild type mice and rats following sleep deprivation and found increased levels of
per1,2 mRNA and decreased levels of dbp mRNA specifically in the cerebral cortex; these changes
subsided with recovery sleep. The expression of per3, cry1,2, clock, npas2, bmal1, and casein-kinase-
1ε did not change with sleep deprivation.
Conclusions: These results indicate that mice lacking cryptochromes are not simply a genetic model
of circadian arrhythmicity in rodents and functionally implicate cryptochromes in the homeostatic
regulation of sleep.
Background
Sleep is regulated by both circadian and homeostatic
mechanisms. As a consequence of a signal from the circa-
dian clock, located in the suprachiasmatic nuclei (SCN) of
the anterior hypothalamus in mammals [1], sleep is more
likely to occur at certain times of the 24-h day than others,
thereby determining the daily sleep-wake distribution [2].
Sleep is homeostatically regulated in the sense that sleep
drive accumulates in the absence of sleep and decreases
during sleep. Changes in sleep drive are thus driven by the
sleep-wake history. Homeostatic and circadian mecha-
nisms interact to determine the duration and quality of
sleep and wakefulness [3–5]. Homeostatic regulation of
sleep can still be observed in animals that lack circadian
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circadian rhythms and sleep homeostasis are independent
processes.
Homeostatic regulation of sleep can be quantified objec-
tively after a period of enforced wakefulness (i.e., sleep
deprivation), although a similar relationship between
sleep parameters and spontaneous wakefulness can be
quantified under baseline conditions as well [10,11]. The
compensatory responses in time spent asleep, sleep con-
solidation (i.e., sleep bout duration; [12]), and/or sleep
intensity observed after an extended period of wakeful-
ness are all taken as evidence that sleep drive is increased
during wakefulness and thus that sleep is homeostatically
regulated. Non-REM sleep (NREMS) intensity, quantified
as EEG power in the delta frequency range (1–4 Hz), and
NREMS consolidation are in a quantitative and predictive
relationship with sleep history: both variables increase
with the duration of prior wakefulness and subsequently
decline during NREMS [3,4,10,12,13]. These variables are
thus quantitative markers of NREMS homeostasis and are
presumed to reflect an underlying physiological drive for
sleep [4].
The time constants describing the dynamics of the increas-
ing NREMS drive during wakefulness and decreasing
NREMS drive during NREMS [10,14] are compatible with
a role for changes in gene expression in their regulation.
Although past studies have shown that extended periods
of wakefulness cause changes in gene expression (for re-
view see [15]), no causal relationship between changes in
gene expression and sleep homeostasis has been identi-
fied. A recent study in Drosophila melanogaster implicates
transcriptional regulation by the circadian gene cycle, a ho-
molog of the mammalian bmal1 gene, in the homeostatic
regulation of rest [16]. While rest in flies shares several
features with sleep in mammals [17,18], it remains to be
determined whether a similar role for BMAL1 or related
transcriptional regulators is necessary for the homeostatic
regulation of sleep.
In both flies and mammals, circadian rhythms are
thought to be generated by transcriptional/translational
feedback loops comprising a network of transcriptional
regulators [19–21]. The core of this self-sustained molec-
ular oscillation consists of positive and negative elements.
In mammals, the positive elements are two basic helix-
loop-helix (bHLH) PAS-domain-containing transcription
factors, CLOCK and BMAL1, that form heterodimers that
can drive the transcription of three period (per) genes per1–
3 and two cryptochromes (cry1,2). PER1,2 and CRY1,2 pro-
teins suppress CLOCK:BMAL1-mediated transcription
thereby forming the negative elements in the feedback
loop. Consistent with their central role in circadian
rhythm generation, genetic inactivation of both crypto-
chromes (cry1,2-/-) results in circadian arrhythmicity in
mice [22,23]. Given the widespread expression of the ele-
ments of the molecular clock in the brain (and elsewhere)
and the large number of genes regulated by bHLH-PAS
transcription factors (e.g. [24]), the role of cryptochromes
may extend beyond circadian clock function. To deter-
mine whether transcriptional regulation by CRY1,2 influ-
ences the homeostatic regulation of sleep, we studied
sleep in cry1,2-/- mice under baseline conditions, under
conditions of constant darkness, and after sleep depriva-
tion (SD). The expression of circadian genes that are regu-
lated by cryptochromes were evaluated in the brain of
cry1,2-/- mice and in sleep deprived wild type mice and
rats.
Results
Sleep regulation in cry1,2-/- mice
In baseline conditions, wild type mice showed the sleep-
wake distribution typical for this nocturnal species with
high values of sleep in the light period and low values in
the dark period (Figure 1, Table 1). The sleep-wake distri-
bution in cry1,2-/- mice was distinct from that of wild type
controls (Figure 1) in that sleep variables did not differ be-
tween the 12-h light (L) and dark (D) periods (Table 1).
Nevertheless, as in wild type controls, the light-to-dark
transition was accompanied by a pronounced decrease in
sleep time in cry1,2-/- mice (Figure 1).
During baseline, total daily NREMS time was significantly
greater in cry1,2-/- mice than in wild type mice (683 ± 25
vs. 576 ± 12 min, P < 0.002, unpaired t-test), whereas the
daily time spent in REM sleep did not differ (118 ± 7 vs.
113 ± 10 min). The difference between genotypes in
NREMS time was present only in the dark period and not
in the light (Table 1; Figure 1). Average NREMS bout du-
ration, a measure of NREMS consolidation that is posi-
tively correlated with a high homeostatic sleep pressure
[13], was greater by 34% in cry1,2-/- mice relative to wild
type mice during the light period, and by 41% during the
dark period (Table 1). Consistent with this increase in
sleep consolidation, NREMS delta power was significantly
higher in cry1,2-/- than in cry1,2+/+ mice during most of
baseline (Figure 1). This difference in EEG delta power
was specific for NREMS and did not extend to other EEG
frequencies (Figure 2A), indicating that the increase in
delta power is not due to a difference in EEG amplifica-
tion. This state-specific EEG difference in delta power was
especially evident at the wake-to-NREMS transition.
cry1,2-/- mice exhibited higher delta power values than
cry1,2+/+ immediately after the onset of NREMS (Figure
2B).
The same genotypic differences in sleep were observed in
constant dark (DD) conditions (Figure 3). Mice lacking
cry1,2 spent more time in NREMS (719 ± 29 vs. 629 ± 29Page 2 of 14
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Time course of sleep (upper panels) and NREMS EEG delta power (lower panel). Data from baseline (BSL), sleep deprivation 
(SD), and recovery (REC) are shown. Open (Cry1,2-/-) and closed (Cry1,2+/+) symbols designate mean hourly values ± 1 SEM. In 
the lower panel, thicker lines connect mean predicted delta power values based on the sleep-wake distribution in individual 
mice; (see Methods). Triangles mark intervals in which recovery values differed from corresponding baseline values within each 
genotype (triangle orientation designates direction of deviation; P < 0.05, post-hoc paired t-tests). Gray bars at the bottom of 
each panel mark intervals with significant genotype differences (P < 0.05, post-hoc t-tests). The baseline dark period was 
depicted twice to illustrate the changes at the dark-to-light transition.Page 3 of 14
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er (3.8 ± 0.3 vs. 2.6 ± 0.1 min, P < 0.001, unpaired t-test),
and EEG delta power in NREMS was higher in cry1,2-/-
compared to cry1,2+/+ controls (594 ± 21 vs. 448 ± 52 µV2/
0.1 Hz, P < 0.04, unpaired t-test; Figure 3). The decrease in
sleep time prior to the onset of the dark period (Figure 1)
was still present in DD in cry1,2+/+ mice; sleep time de-
creased in the latter half of the subjective day and mini-
mum average sleep time was reached immediately after
the onset of the subjective night (Figure 3). The anticipa-
tory decrease in sleep time that occurred prior to the onset
of dark in cry1,2-/- mice in LD did not occur under DD
conditions (Figure 3). Under DD conditions, less REMS
was present in cry1,2-/- mice than in cry1,2+/+ mice (119 ±
7 vs. 149 ± 9 min, P < 0.03, unpaired t-test) due to an in-
crease in REMS in cry1,2+/+ mice in DD (149 ± 9 min) rel-
ative to LD (113 ± 10 min, P < 0.03, paired t-test).
To further investigate the homeostatic regulation of sleep
in cry1,2-/- mice, we assayed the compensatory response to
a 6 h SD (see Figure 1). After SD, wild type mice displayed
the typical increase in REMS and NREMS time, NREMS
bout duration, and EEG delta power above baseline levels
([10,13] Table 2, Figure 1). In contrast, cry1,2-/- mice did
not exhibit significant increases in REMS, NREMS time or
NREMS bout duration after SD; only a brief increase in
NREMS delta power was observed (lasting 1 h in cry1,2-/-
vs. 5 h in wild type mice; Figure 1). The initial increase in
delta power (relative to baseline), measured over the first
recovery hour, was significantly smaller in cry1,2-/- than
the increase observed in wild type mice (Table 2). Delta
power (Figure 1, Table 2) and NREMS bout duration (Ta-
bles 1, 2), in cry1,2-/- mice is maintained at a level only at-
tained by the wild type mice when their sleep pressure was
highest, i.e., at the end of the active or dark period and af-
ter SD.
In wild type mice, EEG delta power still varied as a func-
tion of the sleep-wake history with high values at the end
of the baseline dark period and after the SD and low val-
ues at the end of the light or major rest period (Figure 1).
Presumably due to the altered sleep-wake distribution, the
daily range of EEG delta power values was smaller in
cry1,2-/- mice than in wild type mice (Table 1, Figure 1).
We tested the assumption of a relationship between delta
power and the sleep-wake history by using a mathemati-
cal method that predicts the level of EEG delta power oc-
curring in individual NREMS bouts based on the 42 h
sequence of 10-sec behavioral state scores for individual
animals [10]. With this analytical tool, the time constants
of the increasing delta power during wakefulness and its
decrease during NREMS are estimated. For both geno-
types, delta power in both baseline and recovery from SD
could be reliably predicted on the basis of sleep-wake his-
tory (Figure 1), which is underscored by the highly signif-
icant correlations between empirical and simulated data
(r = 0.91 and 0.87 for cry1,2+/+ and cry1,2-/-, respectively,
P < 0.0001 for both genotypes). Thus, in the absence of
cryptochromes, NREMS delta power varied as a function of
the prior sleep-wake history. However, in cry1,2-/- mice, a
significantly shorter time constant for the increase (i.e., a
faster build-up) of delta power was obtained (τincrease: 5.0
± 0.3 h in cry1,2+/+ vs. 3.5 ± 0.5 h in cry1,2-/-; P < 0.05; un-
Table 1: Sleep in 12-h light and dark periods under baseline conditions in cry1,2+/+ and cry1,2-/- mice.
NREMS amount [%]
light dark Difference
cry1,2+/+ 48.8 ± 1.9# 31.3 ± 2.3 17.5 ± 3.9
cry1,2-/- 49.5 ± 1.9 45.4 ± 1.9* 4.2 ± 1.6*
NREMS bout duration [min]
light dark difference
cry1,2+/+ 2.9 ± 0.2 2.9 ± 0.2 0.1 + 0.2
cry1,2-/- 3.9 ± 0.2* 4.1 ± 0.4* -0.2 + 0.2
REMS amount [%]
light dark Difference
cry1,2+/+ 11.9 ± 1.1# 3.8 ± 1.0 8.2 ± 1.5
cry1,2-/- 8.5 ± 0.5* 7.8 ± 0.7* 0.8 ± 0.8*
Post-hoc comparisons: * P < 0.05 vs. wild type, unpaired t-tests; # P < 0.05 vs. dark period, within same genotype, paired t-tests. Differences repre-
sent the mean of individual light-dark differences.Page 4 of 14
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EEG power in the 1–20 Hz range for NREMS, REM sleep (REMS) and wake during baseline. (A) EEG spectral power in cry1,2-/
- (thick lines) and wild type mice (thin lines). Differences between the genotypes are limited to NREMS delta power. (B) Delta 
power (1–4 Hz) during wake-to-NREMS transitions in the baseline light (left) and dark (right panel) period. Gray horizontal 
bars underneath the curves indicate significant genotype differences (P < 0.05; post-hoc t-tests). Error bars span ± 1 SEM.
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Time course of sleep and NREMS EEG delta power during constant dark conditions (DD). Layout and symbols are same as in 
Figure 1. Gray bars at the bottom of each panel mark intervals with significant genotype differences (P < 0.05, post-hoc t-tests). 
The subjective day is marked with a gray horizontal bar at the top of the upper panel. The first 12-h represents the last dark-
period under baseline (BSL) light-dark conditions.Page 6 of 14
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cline of delta power during NREMS did not differ
(τdecrease: 1.7 ± 0.2 h in cry1,2+/+ vs. 1.8 ± 0.3 h in cry1,2-/
-).
Circadian gene expression in the brain of cry1,2-/- mice
Deletion of the cryptochromes disinhibits the transcription-
al activation of CLOCK:BMAL1 and NPAS2:BMAL1 target
genes, resulting in increased levels of their transcripts in
the SCN, liver, and retina [20,23,25]. We assayed the ex-
pression in the brain of three genes that are known targets
of cryptochrome mediated transcriptional inhibition: albu-
min D-binding protein (dbp [26]), period (per)1, and per2
[20,23,27], in the middle of the daily light period. Con-
firming the earlier studies in other tissues, mRNA levels
for all three genes were higher in the brains of cry1,2-/-
mice compared to wild type mice (Figure 4). This relative
increase was highly significant for all three genes (dbp,
per1: 3.3-fold; per2: 5.6-fold; P < 0.0003, unpaired t-tests,
n = 5/genotype).
Sleep deprivation-induced differences in circadian gene 
expression
Messenger RNA levels for per1,2, cry1,2, and dbp were
quantified by RT-PCR in three brain areas (cerebral cortex,
basal forebrain, and hypothalamus) from C57BL/6 mice
that were sacrificed immediately after 6 h of SD or after 4
h of recovery sleep (ZT10). Significant differences in ex-
pression were observed only in the cortex (Figure 5A) and
not in hypothalamus or basal forebrain (data not shown).
Both per1 and per2 mRNA levels were higher immediately
after SD compared to controls, cry1,2 expression did not
change, and dbp mRNA decreased significantly (Figure
5A). After 4 h of recovery sleep, per1,2 and dbp expression
returned to the normal levels for that time of day (ZT10;
Figure 5A). We also measured the expression of five other
circadian genes: bmal1, clock, npas2, per3, and casein kinase-
1-ε (csnk1e) in the cortex; the levels of these five mRNAs
were not affected by SD (data not shown).
As confirmation of our results in the mouse, we deter-
mined the expression of per2 and per1 in the rat by RT-
PCR and Northern analysis, respectively. In a similar ex-
perimental paradigm, rats were sleep deprived for 6 h and
then either sacrificed immediately after the SD (ZT6), or
after 2 h of recovery sleep (ZT8; n = 5/group). The cortex-
specific increase in per2 mRNA was confirmed by the RT-
PCR analysis and, as in the mouse, per2 expression re-
turned to basal levels after a period of recovery sleep (data
not shown). Northern analysis confirmed that recovery
sleep was associated with a decline in per1 mRNA relative
Table 2: Effect of 6 h SD on sleep time and delta power in cry1,2+/+ and cry1,2-/- mice.
NREMS amount [min]
baseline post-SD difference
cry1,2+/+ 264 ± 9 297 ± 15# 33 ± 8
cry1,2-/- 312 ± 9* 318 ± 9 5 ± 4*
NREMS bout duration [min]
baseline post-SD difference
cry1,2+/+ 2.6 ± 0.1 3.3 ± 0.3# 0.7 ± 0.3
cry1,2-/- 4.2 ± 0.4* 3.7 ± 0.2 -0.4 ± 0.3*
NREMS Delta power [µV2/0.1 Hz]
baseline post-SD difference [%]
cry1,2+/+ 407 ± 59 704 ± 125# 170 ± 14
cry1,2-/- 619 ± 67* 805 ± 40# 134 ± 8*
REMS amount [min]
baseline post-SD difference
cry1,2+/+ 52 ± 6 63 ± 3# 11 ± 7
cry1,2-/- 53 ± 4 58 ± 1 5 ± 3
Post-hoc comparisons: * P < 0.05 vs. wild type, unpaired t-test; # P < 0.05, vs. baseline day, within same genotype, paired t-test. Delta power was 
calculated over the first hour after the SD (ZT6-ZT7). REMS and NREMS amount and bout duration were calculated over 12 hours (ZT6-ZT18). 
Differences indicate mean individual post-SD – baseline differences except for delta power which is calculated as percentage of baseline.Page 7 of 14
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Whole-brain mRNA levels for dbp, per1, and per2 in cry1,2-/- and wild type mice. Levels of all three genes are elevated in cry1,2-
/- mice (KO) relative to wild type (WT) controls at ZT6 when dbp, per1, and per2 mRNAs are lowest in the forebrain of wild 
type mice [37]. In the lower three panels mean (± 1 SEM) expression levels are depicted. β-actin expression was used as an 
internal standard.
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Sleep deprivation alters mRNA levels of per1, per2, and dbp. (A) RT-PCR analysis of the expression of five 'clock'-genes in the 
mouse cortex across four experimental conditions [C = control; R = recovery sleep; SD = sleep deprived; ZT = Zeitgeber 
time (i.e., 6 or 10 h after light-onset)]. g3pdh expression was used as an internal standard. Bars depict mean ± 1 SEM. Asterisks 
denote significant differences (P < 0.05) between the experimental and corresponding control group (Student-Newman-Keuls 
post-hoc tests; 1-way ANOVA factor 'condition': P < 0.05, for per1,2, and dbp only; n = 7/condition) (B) per1 mRNA falls signif-
icantly in rat cortex during a 2-h recovery period (R) subsequent to 6 h SD ending at ZT6 (P < 0.05, t-test). Northern analysis 
was performed on cortex of five sleep-deprived rats and five rats that were allowed 2 h of recovery sleep (ZT8).
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ure 5B).
Discussion
Upon release into constant darkness cry1,2-/- mice imme-
diately become arrhythmic at the behavioral level [22,23],
at the level of SCN electrophysiology [28], and at the cel-
lular/molecular level [23]. Of the available mouse models
for circadian dysfunction, only per1,2 double mutant mice
[29], bmal1 knockout mice [30], and mice with an abla-
tion of the SCN [31] show a similarly dramatic pheno-
type. Thus, cry1,2-/- mice appear to be a suitable model for
studies of the regulation of sleep in the absence of an in-
tact circadian clock.
Under light / dark (LD) conditions, running wheel activity
patterns and, as we show here, the distribution of sleep in
cry1,2-/- mice still exhibit diurnal variation. LD cycles can
influence the expression of sleep by entraining the circadi-
an pacemaker that drives the diurnal rhythm of sleep and/
or by directly affecting the expression of sleep, thereby
'masking' the influence of the pacemaker on sleep. Mask-
ing seems to be the mechanism by which light drives these
rhythms under LD conditions in cry1,2-/- mice [22], since
the daily modulation of NREMS that occurs in cry1,2-/-
mice under a light/dark cycle immediately disappears
upon placement in constant darkness ([22], Figure 3). At
the molecular level, per2 expression (but not that of per1)
is rhythmic in the SCN of cry1,2-/- mice under LD condi-
tions. Upon release into constant dark conditions, per2
rhythmicity disappears concomitant with the immediate
loss of behavioral rhythmicity, suggesting a role for 'light-
driven' per2 expression in generating behavioral rhythms
[23].
The most striking and unexpected finding of the current
study is that, under baseline conditions, cry1,2-/- mice ex-
hibit all the hallmarks of high NREMS pressure, including
more consolidated NREMS, increased NREMS time, and
higher levels of EEG delta power relative to wild type mice
that were attained immediately after NREMS onset. The
failure of cry1,2-/- mice to exhibit a robust increase in any
of these measures after 6 h SD is consistent with the inter-
pretation that these mice are already under high NREMS
pressure during baseline conditions. Determination of the
time constants that most accurately describe the dynamics
of NREMS delta power revealed that during wake, the pro-
pensity for high NREMS delta power increases during
wake in cry1,2-/- mice at a faster rate than in wild type
mice. This could help explain why NREMS delta power is
chronically high in cry1,2-/- mice. The coincidence of high
NREMS time and chronically high delta power in cry1,2-/-
mice is all the more striking when one considers that dur-
ing NREMS, the drive for NREMS should dissipate and re-
sult in lower delta power [14,32].
These findings in cry1,2-/- mice contrast with the findings
of sleep studies in animals that are rendered arrhythmic
by lesioning of the SCN. In nocturnal rodents, lesioning
the SCN results in more fragmented sleep, with lower EEG
delta power, but leaving the daily sleep time unchanged
[6–8,31]. Lesioning the SCN in a diurnal primate, the
squirrel monkey, did result in an increase in NREMS time,
but sleep was more fragmented, with a higher proportion
of 'light' NREMS [5]; i.e., with lower overall levels of EEG
delta power. Furthermore, the homeostatic response to
sleep deprivation does not seem to be altered in SCN-le-
sioned rodents [6–8]. Thus, the sleep characteristics of
cry1,2-/- mice do not support the concept of cry1,2-/- mice
as simply a genetic model for ablation of the circadian
clock in the SCN. Together, these unexpected results are
compatible with a role for cryptochromes in the homeostat-
ic regulation of sleep in addition to their role in generat-
ing circadian rhythms.
Recent observations, including the current report, suggest
a complex interrelationship between homeostatic and cir-
cadian influences on sleep at the molecular level. Deletion
of the cycle gene in Drosophila produces flies that have an
exaggerated homeostatic response to rest deprivation in
addition to their lack of circadian rhythmicity [16]. In a
striking parallel to our current results, flies with a muta-
tion in the cryptochrome gene also exhibit increased rest
time as well as a reduced compensatory response to rest
deprivation (P. Shaw, personal communication). The
clock mutation in mice, which has a profound effect on cir-
cadian rhythmicity [33], decreases NREMS time and con-
solidation under baseline conditions [34]. The clock sleep
phenotype is the inverse of the sleep characteristics we re-
port here for the cry1,2-/- mice and is thus consistent with
CLOCK and CRY1,2 being positive and negative transcrip-
tional regulators, respectively. Albumin D-binding protein
(Dbp) is a transcription factor whose expression is under
the direct transcriptional control of CLOCK:BMAL1 [26].
Deletion of the dbp gene, which results in a shortening of
the circadian period [35], also results in decreased sleep
consolidation and NREMS delta power [36].
We assume that the effects on sleep we observed in cry1,2-
/- mice are a result of a lack of cryptochrome-dependent in-
hibition of the transcriptional activation provided by the
bHLH-PAS heterodimers CLOCK:BMAL1 and
NPAS2:BMAL1 [19,20,37], although cryptochromes  also
play a role in stabilizing and nuclear sequestration of PER
proteins [38], and in photoreception [39]. Lack of crypto-
chromes results in increased mRNA levels of CLOCK/
NPAS2:BMAL1 target genes, including the circadian genes
per1 and per2 [20,23]. The expression of these two genes is
viewed as a state variable of the molecular circadian clock
or a marker of CLOCK/NPAS2:BMAL1-induced transcrip-
tion, although at least per1 transcription can also be (rap-Page 10 of 14
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signaling pathway [42–44]. The observation of high brain
levels of per1,2 transcripts under baseline conditions in
cry1,2-/- mice raises the possibility that these or other
CLOCK/NPAS2:BMAL1 target genes are involved in the
homeostatic regulation of sleep. The observation of ele-
vated per gene expression in the cortex of sleep-deprived
rats and mice (Figure 5) supports this hypothesis.
The increase in per expression after the sleep deprivation
was specific to the cerebral cortex, although it cannot be
ruled out, based on the present study, that circadian gene
expression changes with sleep-wake history in specific nu-
clei within the other two regions examined; i.e., the hy-
pothalamus and basal forebrain. A surprisingly small
number (~0.5%) of the ~10,000 genes screened by mRNA
differential display and cDNA microarrays in the cortex to
date change their expression with sleep deprivation [45].
It is intriguing and encouraging that, of the initial genes
we assayed, three changed their expression with sleep dep-
rivation (per1, per2, dbp), none of which were identified in
the aforementioned screens. cry1,2 expression at the
mRNA level did not change with sleep deprivation in wild
type mice. This observation does not necessarily obviate a
direct role for CRY proteins in mediating a response to
sleep deprivation. CRY poteins may play a role at steady
state levels or there may be post-translational changes in
the functioning of CRY proteins in association with sleep
deprivation, such as phosphorylation state, ubiquitina-
tion [38], or intracellular localization [46] of the protein,
all of which are regulated dynamically, at least in vitro. In
the liver, CRY protein oscillations are not necessary for cir-
cadian oscillations of target transcripts, as CRY proteins
are present in excess of PER and oscillations in the latter
produce rhythmicity [46]. A similar situation might exist
in the cortex.
The high per levels in cry1,2-/- mice and the low per levels
in clock mutant mice [26,47] correlate with their contrast-
ing sleep phenotype (see above; [34]). In this context, the
sleep abnormalities in dbp-/- mice might also be related to
a reduction in per expression since, at least in vitro, DBP
can amplify the CLOCK:BMAL1-induced transcription of
per [48], but it is not known whether per transcript levels
are altered in dbp-/- mice. Apart from the present observa-
tions in sleep-deprived rats and mice, several other reports
confirm that cortical levels of per expression in wild type
animals are high at times when sleep drive is high, irre-
spective of the phase at which the circadian expression of
per peaks in the SCN. Thus, in both nocturnal and diurnal
species, per expression in the cortex is maximal in con-
junction with the major waking episode [37,49,50]. Un-
der conditions where the phase (methamphetamine
administration, restricted feeding) or distribution (circa-
dian splitting) of locomotor activity is altered, per expres-
sion in the cortex parallels the overt rhythm of
wakefulness, whereas the circadian oscillation of per gene
expression in the SCN remains unaffected [49,51,52].
Thus, in contrast to its role in the SCN, PER protein in the
cortex is not a component of a self-sustaining circadian os-
cillator [53]. Instead, per expression in the cortex seems to
the follow sleep-wake history, consistent with the hypoth-
esis that it is related to homeostatic regulation of sleep.
However, in the current study and those cited above, the
expression of per genes was studied at the mRNA level.
PER protein level may be affected differentially from that
of per mRNA and levels of the PER protein are reduced in
cry1,2-/- mice due to reduced stability of PER proteins in
the absence of heterodimerizing CRY partners [19,38,46].
Conclusions
In the discussion, we have focused on per1,2 mRNAs as
transcriptional targets of cry1,2 because the expression
patterns of these circadian genes have been widely de-
scribed and because their transcriptional control by CRY
proteins and by CLOCK/NPAS2:BMAL1 has been well es-
tablished. At least 90 genes are regulated in a similar fash-
ion by NPAS2:BMAL1 [37] and the identity of the target
genes critical for the NREMS phenotype in cry1,2-/- mice
remains to be determined. In the absence of cry1,2, the
stability and overall level of PER proteins, particularly in
the nucleus of the cell, is reduced [19,38,46]. It would
therefore be interesting to observe sleep in per1,2 single
and double mutant mice, the latter of which have been
subjected to behavioral observation [29] but not to sleep
EEG studies. per1 single knockout mice and mice express-
ing a non-functional PER2 protein both exhibit subtle dif-
ferences from wild type in the homeostatic rebound after
SD [54], an observation compatible with the hypothesis
that these genes are correlates of sleep homeostasis. In ad-
dition, measurement of the effects of sleep deprivation on
the expression of cry1,2 and per1,2 genes at the protein
level will provide critical information. Finally, from a
functional perspective, it is interesting that CLOCK/
NPAS2:BMAL1 transcriptional activity is sensitive to re-
dox state [24]. This transcriptional activity might thus pro-
vide a link between neuronal activity and an energy
regulatory function for NREMS, as has been suggested pre-
viously [55].
Methods
Sleep studies
Mice were generated by mating cry1 and cry2 single knock-
out mice, both of mixed background (ca. 3/4 C57BL/6 –
1/4 129/Sv; [23]) to generate double heterozygotes that
were interbred to generate double knockouts (cry1,2-/-)
and wild type controls (cry1,2+/+). Eight wild type and 6
cry1,2-/- male mice were surgically prepared for EEG and
electromyographic (EMG) recordings as described previ-
ously [56]. Following two weeks of post-surgical recovery,Page 11 of 14
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chambers. The experiments were conducted under an
LD12:12 cycle (lights-on; i.e., Zeitgeber Time ZT0, at 0600
h). Twenty-four hour baseline recordings, starting at ZT0,
were followed by a 6 h sleep deprivation (SD) starting at
ZT0. The sleep deprivations in this experiment and the
other two experiments (see below) were performed by the
introduction of novel objects into the cage or by gentle
handling. In addition to the SD experiment, animals were
subjected to one day of baseline recording in constant
darkness separated from the SD experiment by 72 hours.
All experimental procedures complied with institutional
and NIH guidelines.
Digitized EEG and integrated EMG were stored in 10-s ep-
ochs and classified as NREMS, REM sleep (REMS), or
wakefulness by visual inspection. The EEG was subjected
to a Fast-Fourier-Transformation yielding power spectra
between 0–20 Hz. Delta power was calculated as the aver-
age EEG power in the delta (1–4 Hz) frequencies for ep-
ochs scored as NREMS. For visual representation, hourly
delta-power values (Figure 1) were expressed relative to an
individual mean (i.e., 24-h baseline mean) before trans-
forming back to absolute values to capture both the highly
reproducible individual time course of delta power and
the genotype differences in absolute values [10]. Statistical
evaluation of genotype differences were based, however,
on the absolute EEG values. Post-SD delta power was
compared to baseline during the first hour of spontaneous
sleep subsequent to SD, while NREMS amount and bout
duration (Table 2) were compared over 12 hours (ZT6-
ZT18), in accordance with the distinct dynamics of the
compensatory responses of these variables to SD [57].
NREMS bouts were defined as periods of NREMS initiated
by three consecutive 10-second epochs of NREMS and ter-
minated by three consecutive epochs not classified as
NREMS. EEG delta power changes at transitions between
wakefulness and NREMS were measured during those
transitions characterized by at least 12 consecutive 10-s
epochs of wake followed by at least 18 consecutive 10-ep-
ochs of NREMS.
A mathematical algorithm was used to quantify the sleep-
wake dependent dynamics of delta power during both
baseline and recovery from SD [10]. In this algorithm, del-
ta power decreases during NREMS and increases during
wakefulness according to saturating exponential func-
tions, the time constants of which are estimated by mini-
mizing the square of the differences between empirical
(delta power) data and the values produced by the math-
ematical functions. The two time constants (for the in-
crease and decrease of delta power) that resulted in the
smallest deviation from empirical values within each indi-
vidual were used to statistically assess genotype effect on
the dynamics of delta power [10].
Northern analysis
Five cry1,2-/- mice and 5 wild type controls were sacrificed
in the middle of the light period (ZT6). Brains were rapid-
ly removed and frozen on dry ice. Total RNA was extracted
and Northern analysis was performed with 10 µg whole
brain total RNA as previously described [58].
Ten Wistar rats were sleep deprived for 6 h beginning at
light-onset (ZT0). Five rats were sacrificed at ZT6 at the
end of the SD and five were allowed to recover for 2 h fol-
lowing the SD and were sacrificed at ZT8. Rats were mon-
itored by EEG/EMG throughout this period as described
[59]. Brains were rapidly removed, dissected and frozen,
and Northern analysis performed.
Quantitative real-time Reverse-Transcriptase Polymerase-
Chain-Reaction (RT-PCR) analyses
Four experimental groups of male C57BL/6J mice were
studied: 1) sleep deprived from light-onset (ZT0) to ZT6;
2) control mice for the SD group; 3) 6 h SD (ZT0-ZT6) fol-
lowed by 4-h recovery sleep (ZT6-ZT10); and 4) control
mice for the recovery group (n = 7 mice/group). Animals
were sacrificed by decapitation. Brains were rapidly re-
moved and the cerebral cortex, basal forebrain, and hy-
pothalamus were dissected. After a mid-sagittal cut, the
entire cortical tissue was peeled off and separated from the
hippocampus and underlying diencephalon. Striatal tis-
sue was also removed. From each animal, quantitative
real-time PCR determinations of 5 target genes (cry1,2,
per1,2, and dbp) and a reference cDNA (glyceraldehyde-3-
phosphate dehydrogenase, g3pdh) were made from the
cortex, basal forebrain, and hypothalamus (primer/probe
sequences available upon request). For five other targets
(bmal1, clock, npas2, per3, and csnk1e), expression was
quantified in the cortex only. To confirm the specificity of
the nucleotide sequences chosen for the primers and
probes and the absence of DNA polymorphisms, BLASTN
searches were conducted against the dbEST and nonre-
dundant set of Genbank, EMBL, and DDBJ databases.
Dual color fluorescence was detected using an ABI Prism
7700 Sequence Detection System (Perkin-Elmer Corp.,
Foster City, CA). For each experimental sample, the
amount of the target and g3pdh reference was determined
from the standard curve (range of 0.2–200 ng total RNA)
measured in the same assay. A normalized value was ob-
tained by dividing the target cDNA amount by the g3pdh
reference. For details see [59].
Authors' contributions
CPS and AS generated the cry1,2-/- mice and provided
some preliminary data on microarray gene expression
profiles in the brains of these mice. JPW and DME con-
ceived and implemented sleep studies in cry1,2-/- mice. PF
analyzed sleep EEG data and conceived, with BFO, AT,
and TSK, the molecular studies. BFO, AT, and TSK per-Page 12 of 14
(page number not for citation purposes)
BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/20formed gene expression assays on brain tissues from mice
and rats. JPW and PF drafted the manuscript. All authors
read and approved the manuscript.
Acknowledgments
We appreciate the generous gifts of cDNA clones from Drs. Ueli Schibler 
(dbp cDNA), Steven Reppert (per2 cDNA), and Hajime Tei (per1 cDNA). 
Funding was provided by the following NIH grants: HL64243 (JPW and 
DME), R01HL/MH59658 and R01MH61755 (AT and TSK), GM31082 (CPS 
and AS), and HL64148 and DA13349 (BFO and PF).
References
1. Klein DC, Moore RY and Reppert SM Suprachiasmatic nucleus:
The mind's clock. New York: Oxford University Press 1991, 
2. Edgar DM Functional role of the suprachiasmatic nuclei in the
regulation of sleep and wakefulness. In: Fatal Familial Insomnia: In-
herited prion diseases, sleep and the thalamus (Edited by: Guilleminault C)
New York: Raven Press, Ltd 1994, 203-213
3. Dijk DJ and Czeisler CA Contribution of the circadian pace-
maker and the sleep homeostat to sleep propensity, sleep
structure, electroencephalographic slow waves, and sleep
spindle activity in humans. J Neurosci 1995, 15:3526-38
4. Borbely AA and Achermann P Sleep homeostasis and models of
sleep regulation. In: Principles and practice in sleep medicine (Edited by:
Kryger MH, Roth T, Dement WC) Philadelphia: W.B. Saunders 2000, 377-
390
5. Edgar DM, Dement WC and Fuller CA Effect of SCN lesions on
sleep in squirrel monkeys: evidence for opponent processes
in sleep-wake regulation. J Neurosci 1993, 13:1065-79
6. Mistlberger RE, Bergmann BM, Waldenar W and Rechtschaffen A Re-
covery sleep following sleep deprivation in intact and supra-
chiasmatic nuclei-lesioned rats. Sleep 1983, 6:217-33
7. Tobler I, Borbely AA and Groos G The effect of sleep deprivation
on sleep in rats with suprachiasmatic lesions. Neurosci Lett
1983, 42:49-54
8. Trachsel L, Edgar DM, Seidel WF, Heller HC and Dement WC Sleep
homeostasis in suprachiasmatic nuclei-lesioned rats: effects
of sleep deprivation and triazolam administration. Brain Res
1992, 589:253-61
9. Wurts SW and Edgar DM Circadian and homeostatic control of
rapid eye movement (REM) sleep: promotion of REM ten-
dency by the suprachiasmatic nucleus. J Neurosci 2000, 20:4300-
10
10. Franken P, Chollet D and Tafti M The homeostatic regulation of
sleep need is under genetic control. J Neurosci 2001, 21:2610-21
11. Huber R, Deboer T and Tobler I Effects of sleep deprivation on
sleep and sleep EEG in three mouse strains: empirical data
and simulations. Brain Res 2000, 857:8-19
12. Edgar DM and Seidel WF Modafinil induces wakefulness without
intensifying motor activity or subsequent rebound hyper-
somnolence in the rat. J Pharmacol Exp Ther 1997, 283:757-769
13. Franken P, Dijk DJ, Tobler I and Borbely AA Sleep deprivation in
rats: effects on EEG power spectra, vigilance states, and cor-
tical temperature. Am J Physiol 1991, 261:R198-208
14. Daan S, Beersma DG and Borbely AA Timing of human sleep: re-
covery process gated by a circadian pacemaker. Am J Physiol
1984, 246:R161-83
15. Cirelli C How sleep deprivation affects gene expression in the
brain: a review of recent findings. J Appl Physiol 2002, 92:394-400
16. Shaw PJ, Tononi G, Greenspan RJ and Robinson DF Stress response
genes protect against lethal effects of sleep deprivation in
Drosophila. Nature 2002, 417:287-91
17. Shaw PJ, Cirelli C, Greenspan RJ and Tononi G Correlates of sleep
and waking in Drosophila melanogaster. Science 2000,
287:1834-7
18. Hendricks JC, Finn SM, Panckeri KA, Chavkin J, Williams JA, Sehgal A
and Pack AI Rest in Drosophila is a sleep-like state. Neuron 2000,
25:129-38
19. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, May-
wood ES, Hastings MH and Reppert SM mCRY1 and mCRY2 are
essential components of the negative limb of the circadian
clock feedback loop. Cell 1999, 98:193-205
20. Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B,
Kume K, Lee CC, van der Horst GT and Hastings MH Interacting
molecular loops in the mammalian circadian clock. Science
2000, 288:1013-9
21. Reppert SM and Weaver DR Molecular analysis of mammalian
circadian rhythms. Annu Rev Physiol 2001, 63:647-76
22. van der Horst GT, Muijtjens M, Kobayashi K, Takano R, Kanno S,
Takao M, de Wit J, Verkerk A, Eker AP and van Leenen D Mamma-
lian Cry1 and Cry2 are essential for maintenance of circadian
rhythms. Nature 1999, 398:627-30
23. Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM,
Hitomi K, Thresher RJ, Ishikawa T and Miyazaki J Differential regu-
lation of mammalian period genes and circadian rhythmicity
by cryptochromes 1 and 2. Proc Natl Acad Sci U S A 1999, 96:12114-
9
24. Rutter J, Reick M, Wu LC and McKnight SL Regulation of clock and
NPAS2 DNA binding by the redox state of NAD cofactors.
Science 2001, 293:510-4
25. Okamura H, Miyake S, Sumi Y, Yamaguchi S, Yasui A, Muijtjens M,
Hoeijmakers JH and van der Horst GT Photic induction of mPer1
and mPer2 in cry-deficient mice lacking a biological clock. Sci-
ence 1999, 286:2531-4
26. Ripperger JA, Shearman LP, Reppert SM and Schibler U CLOCK, an
essential pacemaker component, controls expression of the
circadian transcription factor DBP. Genes Dev 2000, 14:679-89
27. Griffin EA Jr, Staknis D and Weitz CJ Light-independent role of
CRY1 and CRY2 in the mammalian circadian clock. Science
1999, 286:768-71
28. Albus H, Bonnefont X, Chaves I, Yasui A, Doczy J, van der Horst GT
and Meijer JH Cryptochrome-deficient mice lack circadian
electrical activity in the suprachiasmatic nuclei. Current biology
: CB 2002, 12(13):1130-3
29. Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun
ZS, Eichele G and Bradley A Nonredundant roles of the mPer1
and mPer2 genes in the mammalian circadian clock. Cell 2001,
105:683-94
30. Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA,
Hogenesch JB, Simon MC, Takahashi JS and Bradfield CA Mop3 is an
essential component of the master circadian pacemaker in
mammals. Cell 2000, 103:1009-17
31. Ibuka N, Nihonmatsu I and Sekiguchi S Sleep-wakefulness
rhythms in mice after suprachiasmatic nucleus lesions. Wak-
ing Sleeping 1980, 4:167-73
32. Borbely AA A two process model of sleep regulation. Hum Neu-
robiol 1982, 1:195-204
33. Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, Mc-
Donald JD, Dove WF, Pinto LH, Turek FW and Takahashi JS Muta-
genesis and mapping of a mouse gene, Clock, essential for
circadian behavior. Science 1994, 264:719-725
34. Naylor E, Bergmann BM, Krauski K, Zee PC, Takahashi JS, Vitaterna
MH and Turek FW The circadian clock mutation alters sleep
homeostasis in the mouse. J Neurosci 2000, 20:8138-43
35. Lopez-Molina L, Conquet F, Dubois-Dauphin M and Schibler U The
DBP gene is expressed according to a circadian rhythm in
the suprachiasmatic nucleus and influences circadian behav-
ior. Embo J 1997, 16:6762-71
36. Franken P, Lopez-Molina L, Marcacci L, Schibler U and Tafti M The
transcription factor DBP affects circadian sleep consolida-
tion and rhythmic EEG activity. J Neurosci 2000, 20:617-25
37. Reick M, Garcia JA, Dudley C and McKnight SL NPAS2: an analog
of clock operative in the mammalian forebrain. Science 2001,
293:506-9
38. Yagita K, Tamanini F, Yasuda M, Hoeijmakers JH, van Der Horst GT
and Okamura H Nucleocytoplasmic shuttling and mCRY-de-
pendent inhibition of ubiquitylation of the mPER2 clock pro-
tein. Embo J 2002, 21:1301-1314
39. Selby C, Thompson C, Schmitz T, Van Gelder R and S A Functional
redundancy of cryptochrome and classical photoreceptors for
nonvisual ocular photoreception in mice. Proc Natl Acad Sci, USA
2000, 
40. Albrecht U, Sun ZS, Eichele G and Lee CC A differential response
of two putative mammalian circadian regulators, mper1 and
mper2, to light. Cell 1997, 91:1055-1064
41. Shigeyoshi Y, Taguchi K, Yamamoto S, Takekida S, Yan L, Tei H, Mori-
ya T, Shibata S, Loros JJ and Dunlap JC Light-induced resetting ofPage 13 of 14
(page number not for citation purposes)
BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/20Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
a mammalian circadian clock is associated with rapid induc-
tion of the mPer1 transcript. Cell 1997, 91:1043-1053
42. Yokota S, Yamamoto M, Moriya T, Akiyama M, Fukunaga K, Miyamo-
to E and Shibata S Involvement of calcium-calmodulin protein
kinase but not mitogen-activated protein kinase in light-in-
duced phase delays and Per gene expression in the suprach-
iasmatic nucleus of the hamster. J Neurochem 2001, 77:618-27
43. Tischkau SA, Mitchell JW, Tyan SH, Buchanan GF and Gillette MU
CREB-dependent activation of Per1 is required for light-in-
duced signaling in the suprachiasmatic nucleus circadian
clock. J Biol Chem 2002, 
44. Gau D, Lemberger T, von Gall C, Kretz O, Le Minh N, Gass P, Schmid
W, Schibler U, Korf HW and Schutz G Phosphorylation of CREB
Ser142 regulates light-induced phase shifts of the circadian
clock. Neuron 2002, 34:245-53
45. Cirelli C and Tononi G Gene expression in the brain across the
sleep-waking cycle. Brain Res 2000, 885:303-21
46. Lee C, Etchegaray JP, Cagampang FR, Loudon AS and Reppert SM
Posttranslational mechanisms regulate the mammalian cir-
cadian clock. Cell 2001, 107:855-67
47. Oishi K, Fukui H and Ishida N Rhythmic expression of BMAL1
mRNA is altered in Clock mutant mice: differential regula-
tion in the suprachiasmatic nucleus and peripheral tissues. Bi-
ochem Biophys Res Commun 2000, 268:164-71
48. Yamaguchi S, Mitsui S, Yan L, Yagita K, Miyake S and Okamura H Role
of DBP in the circadian oscillatory mechanism. Mol Cell Biol
2000, 20:4773-81
49. Abe H, Honma S, Namihira M, Masubuchi S and Honma K Behav-
ioural rhythm splitting in the CS mouse is related to clock
gene expression outside the suprachiasmatic nucleus. Eur J
Neurosci 2001, 14:1121-8
50. Mrosovsky N, Edelstein K, Hastings MH and Maywood ES Cycle of
period gene expression in a diurnal mammal (Spermophilus
tridecemlineatus): implications for nonphotic phase shifting.
J Biol Rhythms 2001, 16:471-8
51. Masubuchi S, Honma S, Abe H, Ishizaki K, Namihira M, Ikeda M and
Honma K Clock genes outside the suprachiasmatic nucleus in-
volved in manifestation of locomotor activity rhythm in rats.
Eur J Neurosci 2000, 12:4206-14
52. Wakamatsu H, Yoshinobu Y, Aida R, Moriya T, Akiyama M and Shiba-
ta S Restricted-feeding-induced anticipatory activity rhythm
is associated with a phase-shift of the expression of mPer1
and mPer2 mRNA in the cerebral cortex and hippocampus
but not in the suprachiasmatic nucleus of mice. Eur J Neurosci
2001, 13:1190-6
53. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, Menaker
M and Block GD Circadian rhythms in isolated brain regions. J
Neurosci 2002, 22:350-6
54. Kopp C, Albrecht U, Zheng B and Tobler I Homeostatic sleep reg-
ulation is preserved in mPer1 and mPer2 mutant mice. Eur J
Neurosci 2002, 16:1099-106
55. Benington JH and Heller HC Restoration of brain energy metab-
olism as the function of sleep. Prog Neurobiol 1995, 45:347-360
56. Edgar DM, Kilduff TS, Martin CE and Dement WC Influence of run-
ning wheel activity on free-running sleep/wake and drinking
circadian rhythms in mice. Physiol Behav 1991, 50:373-378
57. Franken P, Malafosse A and Tafti M Genetic determinants of
sleep regulation in inbred mice. Sleep 1999, 22:155-69
58. O'Hara BF, Watson FL, Srere HK, Kumar H, Wiler SW, Welch SK,
Bitting L, Heller HC and Kilduff TS Gene expression in the brain
across the hibernation cycle. J Neurosci 1999, 19:3781-90
59. Terao A, Peyron C, Ding J, Wurts SW, Edgar DM, Heller HC and
Kilduff TS Prepro-hypocretin (prepro-orexin) expression is
unaffected by short-term sleep deprivation in rats and mice.
Sleep 2000, 23:867-74Page 14 of 14
(page number not for citation purposes)
